12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Anthera completes debt financing

Anthera Pharmaceuticals Inc. (NASDAQ:ANTH), Hayward, Calif.
Business: Autoimmune, Cardiovascular
Date completed: 4/5/13
Type: Debt financing
Raised: $20 million
Investors: MidCap Financial; Square 1...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >